Sexual Differences in pERK/ERK due to 17-Beta-Estradiol Treatments
Loading...
Date
Authors
Ferrise, Daniel F.
Advisors
License
DOI
Type
Presentation
Journal Title
Journal ISSN
Volume Title
Publisher
Grantor
Abstract
Alzheimer's disease is an important disease,
affecting both women and men. One area of study
is the effect of 17-beta-Estradiol (E2) on neuroprotection. Females have a sharp increase in
Alzheimer's onset following menopause. The
purpose of this study was to determine where the
cell signaling differences inlay.
Description
Color poster with text, images, and graphs.
Related Material and Data
Citation
Sponsorship
National Science Foundation; University of Wisconsin--Eau Claire Office of Research and Sponsored Programs.